CD73-IN-18

• Description :

  CD73-IN-18 (compound 35j) is an orally available inhibitor of extracellular 5-nucleotidase (CD73) . CD73-IN-18 can be used in anti-cancer research[1].

• UNSPSC :

  12352005

• Target :

  CD73

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cd73-in-18.html

• Smiles :

  O=C(C(C1=CC(NCCC2=CC=CC=C2)=C(N=N1)C3=COC=C3)=CN4)NC4=O

• Molecular Formula :

  C20H17N5O3

• Molecular Weight :

  375.38

• References & Citations :

  [1]Xu Y, et al. Discovery of Novel 5- (Pyridazin-3-yl) pyrimidine-2,4 (1H,3H) -dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase. J Med Chem. 2024 Oct 10.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [3037968-61-6]